Osteoporosis X-ray: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
[[X-rays|X-ray]] may be helpful in the [[diagnosis]] of [[osteoporosis]]. The main finding on [[x-ray]] suggestive of [[osteoporosis]] is [[bone]] mass loss, identified with decreased bony [[trabecula]] in primary stages and then decreased [[Cortical bone|cortical thickness]]. The most common [[bones]] monitored for [[osteoporosis]] evidences are [[femoral neck]], [[lumbar vertebrae]], and [[calcaneus]]. [[Radiography|Plain radiography]] needs at least 30-50% of [[bone]] loss to demonstrate decreased [[bone density]]; therefore, it is not a very sensitive [[modality]].
[[Radiography|Plain radiography]] needs at least 30-50% of [[bone]] loss to demonstrate decreased [[bone density]]; therefore, it is not a very sensitive [[modality]].
 
The most important [[modality]] for measuring [[Bone mineral density|bone mineral density (BMD)]], that every [[osteoporosis]] diagnostic and [[therapeutic]] decision are based on, is [[Dual energy X-ray absorptiometry|dual energy X-ray absorptiometry (DEXA)]]. [[Dual energy X-ray absorptiometry|DEXA]] is a 2-dimensional image of a 3-demensional subject, mainly depends on size of the [[bone]] which is studied; therefore, it would explain the variety of [[Bone mineral density|BMD]] upon sex, [[body weight]], and also [[Ethnicity and health|ethnicity]]. Regarding the vast advantages of [[Dual energy X-ray absorptiometry|DEXA]], it seems that [[Dual energy X-ray absorptiometry|DEXA]] will remain the masterpiece of [[fracture]] risk assessment and also [[osteoporosis]] diagnosis.


==Osteoporosis X-ray==
==Osteoporosis X-ray==
Line 39: Line 41:


=== Dual energy X-ray absorptiometery (DEXA, DXA) ===
=== Dual energy X-ray absorptiometery (DEXA, DXA) ===
* The most important modality for measuring bone mineral density (BMD), that every osteoporosis diagnostic and therapeutic decision are based on, is dual energy X-ray absorptiometry (DEXA).<ref name="pmid27048946">{{cite journal |vauthors=Messina C, Monaco CG, Ulivieri FM, Sardanelli F, Sconfienza LM |title=Dual-energy X-ray absorptiometry body composition in patients with secondary osteoporosis |journal=Eur J Radiol |volume=85 |issue=8 |pages=1493–8 |year=2016 |pmid=27048946 |doi=10.1016/j.ejrad.2016.03.018 |url=}}</ref> DEXA is a 2-dimensional image of a 3-demensional subject, mainly depends on size of the bone which is studied; therefore, it would explain the variety of BMD upon sex, body weight, and also ethnicity.<ref name="pmid9589631">{{cite journal |vauthors=Seeman E |title=Growth in bone mass and size--are racial and gender differences in bone mineral density more apparent than real? |journal=J. Clin. Endocrinol. Metab. |volume=83 |issue=5 |pages=1414–9 |year=1998 |pmid=9589631 |doi=10.1210/jcem.83.5.4844 |url=}}</ref>
* The most important [[modality]] for measuring [[Bone mineral density|bone mineral density (BMD)]], that every [[osteoporosis]] diagnostic and [[therapeutic]] decision are based on, is [[Dual energy X-ray absorptiometry|dual energy X-ray absorptiometry (DEXA)]].<ref name="pmid27048946">{{cite journal |vauthors=Messina C, Monaco CG, Ulivieri FM, Sardanelli F, Sconfienza LM |title=Dual-energy X-ray absorptiometry body composition in patients with secondary osteoporosis |journal=Eur J Radiol |volume=85 |issue=8 |pages=1493–8 |year=2016 |pmid=27048946 |doi=10.1016/j.ejrad.2016.03.018 |url=}}</ref> [[Dual energy X-ray absorptiometry|DEXA]] is a 2-dimensional image of a 3-demensional subject, mainly depends on size of the [[bone]] which is studied; therefore, it would explain the variety of [[Bone mineral density|BMD]] upon sex, [[body weight]], and also [[Ethnicity and health|ethnicity]].<ref name="pmid9589631">{{cite journal |vauthors=Seeman E |title=Growth in bone mass and size--are racial and gender differences in bone mineral density more apparent than real? |journal=J. Clin. Endocrinol. Metab. |volume=83 |issue=5 |pages=1414–9 |year=1998 |pmid=9589631 |doi=10.1210/jcem.83.5.4844 |url=}}</ref>
* Considering the effect of bone size on 2-dimensional image of DEXA, the measured BMD is not reflecting the exact BMD; however, the DEXA fracture prediction would be better than 3-dimansional images, because small bones fractured easily than large bones.<ref name="pmid18348697">{{cite journal |vauthors=Black DM, Bouxsein ML, Marshall LM, Cummings SR, Lang TF, Cauley JA, Ensrud KE, Nielson CM, Orwoll ES |title=Proximal femoral structure and the prediction of hip fracture in men: a large prospective study using QCT |journal=J. Bone Miner. Res. |volume=23 |issue=8 |pages=1326–33 |year=2008 |pmid=18348697 |pmc=2680175 |doi=10.1359/jbmr.080316 |url=}}</ref>
* Considering the effect of [[bone]] size on 2-dimensional image of [[Dual energy X-ray absorptiometry|DEXA]], the measured [[Bone mineral density|BMD]] is not reflecting the exact [[Bone mineral density|BMD]]; however, the [[Dual energy X-ray absorptiometry|DEXA]] [[fracture]] prediction would be better than 3-dimansional images, because small [[bones]] [[Fracture|fractured]] easily than large [[bones]].<ref name="pmid18348697">{{cite journal |vauthors=Black DM, Bouxsein ML, Marshall LM, Cummings SR, Lang TF, Cauley JA, Ensrud KE, Nielson CM, Orwoll ES |title=Proximal femoral structure and the prediction of hip fracture in men: a large prospective study using QCT |journal=J. Bone Miner. Res. |volume=23 |issue=8 |pages=1326–33 |year=2008 |pmid=18348697 |pmc=2680175 |doi=10.1359/jbmr.080316 |url=}}</ref>
* DEXA is the choice modality because of the following factors:
* [[Dual energy X-ray absorptiometry|DEXA]] is the choice [[modality]] because of the following factors:
*# Short duration of procedure
*# Short duration of procedure
*# High validity in BMD measurement (accuracy)
*# High [[validity]] in [[Bone mineral density|BMD]] measurement (accuracy)
*# High reliability in BMD measurement (reproducible)
*# High [[reliability]] in [[Bone mineral density|BMD]] measurement (reproducible)
*# High range of application (different bone sites)<ref name="pmid12377088">{{cite journal |vauthors=Cummings SR, Bates D, Black DM |title=Clinical use of bone densitometry: scientific review |journal=JAMA |volume=288 |issue=15 |pages=1889–97 |year=2002 |pmid=12377088 |doi= |url=}}</ref>
*# High range of application (different [[bone]] sites)<ref name="pmid12377088">{{cite journal |vauthors=Cummings SR, Bates D, Black DM |title=Clinical use of bone densitometry: scientific review |journal=JAMA |volume=288 |issue=15 |pages=1889–97 |year=2002 |pmid=12377088 |doi= |url=}}</ref>
* There are many factors influencing the osteoporosis diagnosis, such as trabecular bone architecture; however, DEXA is the best predictor of osteoporosis and osteoporotic fractures by means of central BMD surveys.<ref name="pmid21427343">{{cite journal |vauthors=Lorente-Ramos R, Azpeitia-Armán J, Muñoz-Hernández A, García-Gómez JM, Díez-Martínez P, Grande-Bárez M |title=Dual-energy x-ray absorptiometry in the diagnosis of osteoporosis: a practical guide |journal=AJR Am J Roentgenol |volume=196 |issue=4 |pages=897–904 |year=2011 |pmid=21427343 |doi=10.2214/AJR.10.5416 |url=}}</ref>
* There are many factors influencing the [[osteoporosis]] diagnosis, such as [[trabecular bone]] architecture; however, [[Dual energy X-ray absorptiometry|DEXA]] is the best predictor of [[osteoporosis]] and osteoporotic [[fractures]] by means of central [[Bone mineral density|BMD]] surveys.<ref name="pmid21427343">{{cite journal |vauthors=Lorente-Ramos R, Azpeitia-Armán J, Muñoz-Hernández A, García-Gómez JM, Díez-Martínez P, Grande-Bárez M |title=Dual-energy x-ray absorptiometry in the diagnosis of osteoporosis: a practical guide |journal=AJR Am J Roentgenol |volume=196 |issue=4 |pages=897–904 |year=2011 |pmid=21427343 |doi=10.2214/AJR.10.5416 |url=}}</ref>
* For adults, it has to be always two sites of BMD measurement, Lumbar spine and femoral neck; in case each of them is impossible to evaluate, forearm will be substituted.<ref name="pmid18442754">{{cite journal |vauthors=Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Lewiecki EM, Silverman S |title=Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference |journal=J Clin Densitom |volume=11 |issue=1 |pages=75–91 |year=2008 |pmid=18442754 |doi=10.1016/j.jocd.2007.12.007 |url=}}</ref>
* For adults, it has to be always two sites of [[Bone mineral density|BMD]] measurement, [[lumbar spine]] and [[Femur neck|femoral neck]]; in case each of them is impossible to evaluate, [[forearm]] will be substituted.<ref name="pmid18442754">{{cite journal |vauthors=Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Lewiecki EM, Silverman S |title=Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference |journal=J Clin Densitom |volume=11 |issue=1 |pages=75–91 |year=2008 |pmid=18442754 |doi=10.1016/j.jocd.2007.12.007 |url=}}</ref>
* For children (less than 20 years old), femoral maturity level may be different among population, leading to lack of unique reference measure; thus, just one site of measurement (i.e., lumbar spine) is considered.<ref name="pmid18442749">{{cite journal |vauthors=Baim S, Leonard MB, Bianchi ML, Hans DB, Kalkwarf HJ, Langman CB, Rauch F |title=Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference |journal=J Clin Densitom |volume=11 |issue=1 |pages=6–21 |year=2008 |pmid=18442749 |doi=10.1016/j.jocd.2007.12.002 |url=}}</ref>
* For children (less than 20 years old), [[femoral]] [[Maturity (psychological)|maturity]] level may be different among population, leading to lack of unique reference measure; thus, just one site of measurement (i.e., [[lumbar spine]]) is considered.<ref name="pmid18442749">{{cite journal |vauthors=Baim S, Leonard MB, Bianchi ML, Hans DB, Kalkwarf HJ, Langman CB, Rauch F |title=Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference |journal=J Clin Densitom |volume=11 |issue=1 |pages=6–21 |year=2008 |pmid=18442749 |doi=10.1016/j.jocd.2007.12.002 |url=}}</ref>
* Upon the world health organization (WHO) report in 1994, using T-score (standard deviations (SD) below or above the average of young Caucasian women), BMD measures are divided into three groups, include:
* Upon the [[World Health Organization|world health organization (WHO)]] report in 1994, using T-score ([[Standard deviation|standard deviations (SD)]] below or above the average of young Caucasian women), [[Bone mineral density|BMD]] measures are divided into three groups, include:
*# T-score greater than -1.0 SD assumed as normal BMD
*# T-score greater than -1.0 [[Standard deviation|SD]] assumed as normal [[Bone mineral density|BMD]]
*# T-score between -1.0 and -2.5 SD assumed as osteopenia
*# T-score between -1.0 and -2.5 [[Standard deviation|SD]] assumed as [[osteopenia]]
*# T-score less than -2.5 SD assumed as osteoporosis<ref name="urlWHO IRIS: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis : report of a WHO study group [meeting held in Rome from 22 to 25 June 1992]">{{cite web |url=http://apps.who.int/iris/handle/10665/39142 |title=WHO IRIS: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis : report of a WHO study group [meeting held in Rome from 22 to 25 June 1992] |format= |work= |accessdate=}}</ref>
*# T-score less than -2.5 [[Standard deviation|SD]] assumed as [[osteoporosis]]<ref name="urlWHO IRIS: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis : report of a WHO study group [meeting held in Rome from 22 to 25 June 1992]">{{cite web |url=http://apps.who.int/iris/handle/10665/39142 |title=WHO IRIS: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis : report of a WHO study group [meeting held in Rome from 22 to 25 June 1992] |format= |work= |accessdate=}}</ref>
* Z-score is same as the T-score, but the target population is matched for age, sex, race, and also in some studies, weight.
* [[Z-score]] is same as the T-score, but the target population is matched for [[age]], sex, [[race]], and also in some studies, [[weight]].
* Using DEXA in men, almost always show higher BMD levels. But regarding the effect of bone size on DEXA measured BMD levels, it seems that higher BMD levels may be due to larger bones in men. Surprisingly, after matching the BMD levels, it is concluded that volumetric BMD is even lower in men. However, their fracture risk is same as women's risk; thus, the reference range of BMD for women assume for men, too.<ref name="pmid22057550">{{cite journal |vauthors=Srinivasan B, Kopperdahl DL, Amin S, Atkinson EJ, Camp J, Robb RA, Riggs BL, Orwoll ES, Melton LJ, Keaveny TM, Khosla S |title=Relationship of femoral neck areal bone mineral density to volumetric bone mineral density, bone size, and femoral strength in men and women |journal=Osteoporos Int |volume=23 |issue=1 |pages=155–62 |year=2012 |pmid=22057550 |pmc=3640410 |doi=10.1007/s00198-011-1822-8 |url=}}</ref>
* Using [[Dual energy X-ray absorptiometry|DEXA]] in men, almost always show higher [[Bone mineral density|BMD]] levels. But regarding the effect of [[bone]] size on [[Dual energy X-ray absorptiometry|DEXA]] measured [[Bone mineral density|BMD]] levels, it seems that higher [[Bone mineral density|BMD]] levels may be due to larger [[bones]] in men. Surprisingly, after matching the [[Bone mineral density|BMD]] levels, it is concluded that volumetric [[Bone mineral density|BMD]] is even lower in men. However, their [[fracture]] risk is same as women's risk; thus, the women's reference range of [[Bone mineral density|BMD]] is assumed for men, too.<ref name="pmid22057550">{{cite journal |vauthors=Srinivasan B, Kopperdahl DL, Amin S, Atkinson EJ, Camp J, Robb RA, Riggs BL, Orwoll ES, Melton LJ, Keaveny TM, Khosla S |title=Relationship of femoral neck areal bone mineral density to volumetric bone mineral density, bone size, and femoral strength in men and women |journal=Osteoporos Int |volume=23 |issue=1 |pages=155–62 |year=2012 |pmid=22057550 |pmc=3640410 |doi=10.1007/s00198-011-1822-8 |url=}}</ref>
* Regarding the vast advantages of DEXA (low radiation exposure, high availability, and tremendous information related to fracture risk), it seems that DEXA will remain the masterpiece of fracture risk assessment and also osteoporosis diagnosis.<ref name="pmid28716497">{{cite journal |vauthors=Jain RK, Vokes T |title=Dual-energy X-ray Absorptiometry |journal=J Clin Densitom |volume= |issue= |pages= |year=2017 |pmid=28716497 |doi=10.1016/j.jocd.2017.06.014 |url=}}</ref>  
* Regarding the vast advantages of [[Dual energy X-ray absorptiometry|DEXA]] (low [[radiation exposure]], high availability, and tremendous information related to [[fracture]] risk), it seems that [[Dual energy X-ray absorptiometry|DEXA]] will remain the masterpiece of [[fracture]] risk assessment and also [[osteoporosis]] diagnosis.<ref name="pmid28716497">{{cite journal |vauthors=Jain RK, Vokes T |title=Dual-energy X-ray Absorptiometry |journal=J Clin Densitom |volume= |issue= |pages= |year=2017 |pmid=28716497 |doi=10.1016/j.jocd.2017.06.014 |url=}}</ref>  
 


{| align="center"
{| align="center"

Revision as of 16:34, 9 August 2017

Osteoporosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Osteoporosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Life Style Modification
Pharmacotherapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Osteoporosis X-ray On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Osteoporosis X-ray

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Osteoporosis X-ray

CDC on Osteoporosis X-ray

Osteoporosis X-ray in the news

Blogs on Osteoporosis X-ray

Directions to Hospitals Treating Osteoporosis

Risk calculators and risk factors for Osteoporosis X-ray

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Plain radiography needs at least 30-50% of bone loss to demonstrate decreased bone density; therefore, it is not a very sensitive modality.

The most important modality for measuring bone mineral density (BMD), that every osteoporosis diagnostic and therapeutic decision are based on, is dual energy X-ray absorptiometry (DEXA). DEXA is a 2-dimensional image of a 3-demensional subject, mainly depends on size of the bone which is studied; therefore, it would explain the variety of BMD upon sex, body weight, and also ethnicity. Regarding the vast advantages of DEXA, it seems that DEXA will remain the masterpiece of fracture risk assessment and also osteoporosis diagnosis.

Osteoporosis X-ray

Plain X-ray

Vertebra-plana - Case courtesy of Radswiki, Radiopaedia.org, rID: 12072

Lumbar vertebrae

Femoral neck

Tubular bones

Dual energy X-ray absorptiometery (DEXA, DXA)

Osteopenia - Case courtesy of Dr Henry Knipe, Radiopaedia.org, rID 45995
Osteopenia with forearm measurement - Case courtesy of Dr Henry Knipe, Radiopaedia.org, rID 45996
Osteoporosis - Case courtesy of Dr Henry Knipe, Radiopaedia.org, rID 45997

References

  1. 1.0 1.1 "Osteoporosis | Radiology Reference Article | Radiopaedia.org".
  2. "Singh index | Radiology Reference Article | Radiopaedia.org".
  3. Messina C, Monaco CG, Ulivieri FM, Sardanelli F, Sconfienza LM (2016). "Dual-energy X-ray absorptiometry body composition in patients with secondary osteoporosis". Eur J Radiol. 85 (8): 1493–8. doi:10.1016/j.ejrad.2016.03.018. PMID 27048946.
  4. Seeman E (1998). "Growth in bone mass and size--are racial and gender differences in bone mineral density more apparent than real?". J. Clin. Endocrinol. Metab. 83 (5): 1414–9. doi:10.1210/jcem.83.5.4844. PMID 9589631.
  5. Black DM, Bouxsein ML, Marshall LM, Cummings SR, Lang TF, Cauley JA, Ensrud KE, Nielson CM, Orwoll ES (2008). "Proximal femoral structure and the prediction of hip fracture in men: a large prospective study using QCT". J. Bone Miner. Res. 23 (8): 1326–33. doi:10.1359/jbmr.080316. PMC 2680175. PMID 18348697.
  6. Cummings SR, Bates D, Black DM (2002). "Clinical use of bone densitometry: scientific review". JAMA. 288 (15): 1889–97. PMID 12377088.
  7. Lorente-Ramos R, Azpeitia-Armán J, Muñoz-Hernández A, García-Gómez JM, Díez-Martínez P, Grande-Bárez M (2011). "Dual-energy x-ray absorptiometry in the diagnosis of osteoporosis: a practical guide". AJR Am J Roentgenol. 196 (4): 897–904. doi:10.2214/AJR.10.5416. PMID 21427343.
  8. Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Lewiecki EM, Silverman S (2008). "Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference". J Clin Densitom. 11 (1): 75–91. doi:10.1016/j.jocd.2007.12.007. PMID 18442754.
  9. Baim S, Leonard MB, Bianchi ML, Hans DB, Kalkwarf HJ, Langman CB, Rauch F (2008). "Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference". J Clin Densitom. 11 (1): 6–21. doi:10.1016/j.jocd.2007.12.002. PMID 18442749.
  10. "WHO IRIS: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis : report of a WHO study group [meeting held in Rome from 22 to 25 June 1992]".
  11. Srinivasan B, Kopperdahl DL, Amin S, Atkinson EJ, Camp J, Robb RA, Riggs BL, Orwoll ES, Melton LJ, Keaveny TM, Khosla S (2012). "Relationship of femoral neck areal bone mineral density to volumetric bone mineral density, bone size, and femoral strength in men and women". Osteoporos Int. 23 (1): 155–62. doi:10.1007/s00198-011-1822-8. PMC 3640410. PMID 22057550.
  12. Jain RK, Vokes T (2017). "Dual-energy X-ray Absorptiometry". J Clin Densitom. doi:10.1016/j.jocd.2017.06.014. PMID 28716497.

Template:WS Template:WH